BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35659142)

  • 1. Dermatologic Management of Hidradenitis Suppurativa and Impact on Pregnancy and Breastfeeding.
    Chellappan B; Nguyen DDQ; Hoyer P; Ross L
    Cutis; 2022 Mar; 109(3):160-162. PubMed ID: 35659142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy and breastfeeding in hidradenitis suppurativa: A review of medication safety.
    Collier EK; Seivright JR; Shi VY; Hsiao JL
    Dermatol Ther; 2021 Jan; 34(1):e14674. PubMed ID: 33320387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Hidradenitis Suppurativa Disease Course During Pregnancy and Postpartum.
    Lyons AB; Peacock A; McKenzie SA; Jacobsen G; Naik HB; Shi VY; Hamzavi IH; Hsiao JL
    JAMA Dermatol; 2020 Jun; 156(6):681-685. PubMed ID: 32347884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women of Childbearing Age With Hidradenitis Suppurativa Frequently Prescribed Medications With Pregnancy Risk.
    Rivin GM; Fleischer AB
    J Drugs Dermatol; 2023 Jul; 22(7):706-709. PubMed ID: 37410037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Pregnancy on Hidradenitis Suppurativa Disease Course: A Systematic Review and Meta-Analysis.
    Seivright JR; Villa NM; Grogan T; Parvataneni RK; Thompson AM; Shi VY; Hsiao JL
    Dermatology; 2022; 238(2):260-266. PubMed ID: 34515085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Don't forget these 5 things when treating hidradenitis suppurativa.
    Tracey EH
    Cutis; 2019 Nov; 104(5):E27-E28. PubMed ID: 31886798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of hidradenitis suppurativa in pregnancy.
    Perng P; Zampella JG; Okoye GA
    J Am Acad Dermatol; 2017 May; 76(5):979-989. PubMed ID: 28040373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient Perspectives on Hidradenitis Suppurativa and Infertility: A Survey Study.
    Masson R; Shih T; Park S; De DR; Gierbolini A; Alavi A; Garg A; Micheletti RG; Shi VY; Hsiao JL
    Dermatology; 2023; 239(5):732-737. PubMed ID: 37385230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gynecological aspects of hidradenitis suppurativa].
    Kiss N; Plázár D; Lőrincz K; Bánvölgyi A; Valent S; Wikonkál N
    Orv Hetil; 2019 Feb; 160(8):291-299. PubMed ID: 30773037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical management and wound care approaches for hidradenitis suppurativa.
    Antia C; Alavi A; Alikhan A
    Semin Cutan Med Surg; 2017 Jun; 36(2):58-61. PubMed ID: 28538745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hidradenitis suppurativa presenting as mammillary fistula in a teenage girl.
    Barker C; Duff D; Wine Lee L
    Pediatr Dermatol; 2023; 40(5):958-959. PubMed ID: 37114523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hidradenitis suppurativa for the dermatologic hospitalist.
    Charrow A; Savage KT; Flood K; Kimball AB
    Cutis; 2019 Nov; 104(5):276-280. PubMed ID: 31886786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey-based study evaluating breastfeeding decisions and their impact on management in patients with hidradenitis suppurativa.
    Westerkam L; Masson R; Hsiao J; Sayed CJ
    J Am Acad Dermatol; 2024 May; 90(5):1023-1025. PubMed ID: 38185255
    [No Abstract]   [Full Text] [Related]  

  • 15. Adalimumab Treatment in Women With Moderate-to-Severe Hidradenitis Suppurativa from the Placebo-Controlled Portion of a Phase 2, Randomized, Double-Blind Study.
    Gottlieb A; Menter A; Armstrong A; Ocampo C; Gu Y; Teixeira HD
    J Drugs Dermatol; 2016 Oct; 15(10):1192-1196. PubMed ID: 27741335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Special considerations for women with hidradenitis suppurativa.
    Collier E; Shi VY; Parvataneni RK; Lowes MA; Hsiao JL
    Int J Womens Dermatol; 2020 Mar; 6(2):85-88. PubMed ID: 32258337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging medical treatments for hidradenitis suppurativa.
    Lyons AB; Shabeeb N; Nicholson CL; Braunberger TL; Peacock A; Hamzavi IH
    J Am Acad Dermatol; 2020 Aug; 83(2):554-562. PubMed ID: 32289386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.
    Gulliver W; Zouboulis CC; Prens E; Jemec GB; Tzellos T
    Rev Endocr Metab Disord; 2016 Sep; 17(3):343-351. PubMed ID: 26831295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hidradenitis suppurativa in the pediatric population.
    Liy-Wong C; Pope E; Lara-Corrales I
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S36-41. PubMed ID: 26470613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of adolescents with hidradenitis suppurativa.
    Collier E; Shi VY; Hsiao JL
    J Dermatolog Treat; 2021 Dec; 32(8):1035-1038. PubMed ID: 31933397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.